-transparent.png){kind=logo}
Changes in leukotriene C4 levels during different degrees of myocardial ischemia in humans were examined by comparing radioimmunoassay measures of leukotriene C4 plasma levels obtained during transient and prolonged myocardial ischemia. Leukotriene C4 levels in systemic arterial and coronary sinus blood were determined in patients with chronic stable angina before and after myocardial ischemia induced either by exercise (supine bicycle ergometer exercise stress testing; n = 14; age, 52 +/- 8 years) or by coronary occlusion during angioplasty (n = 14; age 53 +/- 7 years). Temporal changes of leukotriene C4 were also followed in arterial and pulmonary artery blood within 24 h after the onset of chest pain (acute phase), and 1 day, 1 week, and 1 month later in 22 patients with acute myocardial infarction (AMI) (12 patients with thrombolytic therapy, age 61 +/- 10 years; 10 patients without thrombolytic therapy, age 60 +/- 11 years). Clinical characteristics, including coronary risk factors and the severity of coronary artery disease, were not significantly different among the groups. Exercise-induced myocardial ischemia and coronary occlusion did not induce any significant leukotriene C4 changes in the chronic stable angina patients, whereas AMI patients had significantly higher plasma leukotriene C4 levels in both arterial and pulmonary artery blood in the acute phase compared with those of chronic stable angina patients (arterial blood, 471 +/- 164 pg/ml and 477 +/- 235 pg/ml vs. 275 +/- 254 pg/ml or 240 +/- 66 pg/ml, p < 0.05; pulmonary artery blood in AMI, 543 +/- 162 pg/ml vs. 234 +/- 125 pg/ml or 225 +/- 64 pg/ml, coronary sinus blood in chronic stable angina, p < 0.05). These results suggest that leukotriene C4 is involved more in prolonged myocardial ischemia than in transient myocardial ischemia, and that leukocyte function might play a significant role in the pathogenesis of patients with AMI.
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
June 1994,
American journal of surgery,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
January 1985,
Advances in prostaglandin, thromboxane, and leukotriene research,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
June 2007,
The Journal of surgical research,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
April 1988,
The British journal of radiology,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
March 2007,
Biochemical pharmacology,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
June 1986,
Annals of neurology,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
January 2001,
International journal of cardiology,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
August 1991,
Prostaglandins, leukotrienes, and essential fatty acids,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
October 1999,
Neurochemical research,
B Takase, and
A Kurita, and
T Maruyama, and
A Uehata, and
T Nishioka, and
K Mizuno, and
H Nakamura, and
K Katsura, and
Y Kanda
December 1987,
Arerugi = [Allergy],
